Gapping up
In reaction to strong earnings/guidance: WSCI +9.2%, CYCC +6.3%, TRQ +5.5%, AMPH +2.4%, REX +2.4%, SONC +0.4%
M&A news: KFX +45.7% (Lexmark to acquire Kofax), KRFT +34.5% (Kraft Foods and H.J. Heinz Company merge to create The Kraft Heinz Company), FXCM +8.2% (announces intent to sell FXCM Japan to Rakuten Sec for $62 mln STMP +7.2% (to Acquire Endicia From Newell), LXK +7.1% (Lexmark to acquire Kofax)
Select solar stocks trading higher: RGSE +16.2%, ASTI +2.3%, JKS +2% (announced that it will supply 104 MW dc of PV solar panels for the Utah Red Hills Renewable Park project), SOL +1.3%, CSUN +1.1%
Select oil/gas related names showing strength: RIG +2.9%, BP +1.5%, RDS.A +1.5%, SDRL +1.3%
Other news: ONCY +20.4% (announces the receipt of Orphan Drug Status from the European Medicines Agency for REOLYSIN to treat ovarian cancer), VBLT +19.7% (reports interim topline results from Phase 2 clinical trial of VB-111 to treat recurrent glioblastoma), NAVB +8.1% (announces that data from its Lymphoseek injection studies in melanoma, breast and oral cavity squamous cell cancers will be presented will be presented at the 68th Annual Cancer Symposium of the Society of Surgical Oncology), MRNS +6.5% (receives FDA Orphan Drug Designation in PCDH19 female epilepsy), BLRX +5.3% (announces successful top-line results from the Phase 1 safety and efficacy study of its lead clinical candidate),RGLS +3.1% (receives Orphan Medicinal Product Designation from the European Commission for RG-012), CLDN +2.7% ( received Emergency Use Authorization from the FDA for Xpert Ebola, a molecular diagnostic test for Ebola Zaire Virus), AHS +2.5% (favorable commentary on Tuesday's Mad Money), WWAV +2.4% (in symp with KRFT), GIS +2% (in symp with KRFT), RIO +1.8% (in connection with TRQ news), MRK +1.6% (announced new $10 bln share repurchase program)
Analyst comments: GRPN +2.8% (upgraded to Buy from Hold at Wunderlich), NTT +1.4% (upgraded to Overweight from Equal Weight at Barclays), URI +0.9% (initiated with a Outperform at Wells Fargo)
In reaction to strong earnings/guidance: WSCI +9.2%, CYCC +6.3%, TRQ +5.5%, AMPH +2.4%, REX +2.4%, SONC +0.4%
M&A news: KFX +45.7% (Lexmark to acquire Kofax), KRFT +34.5% (Kraft Foods and H.J. Heinz Company merge to create The Kraft Heinz Company), FXCM +8.2% (announces intent to sell FXCM Japan to Rakuten Sec for $62 mln STMP +7.2% (to Acquire Endicia From Newell), LXK +7.1% (Lexmark to acquire Kofax)
Select solar stocks trading higher: RGSE +16.2%, ASTI +2.3%, JKS +2% (announced that it will supply 104 MW dc of PV solar panels for the Utah Red Hills Renewable Park project), SOL +1.3%, CSUN +1.1%
Select oil/gas related names showing strength: RIG +2.9%, BP +1.5%, RDS.A +1.5%, SDRL +1.3%
Other news: ONCY +20.4% (announces the receipt of Orphan Drug Status from the European Medicines Agency for REOLYSIN to treat ovarian cancer), VBLT +19.7% (reports interim topline results from Phase 2 clinical trial of VB-111 to treat recurrent glioblastoma), NAVB +8.1% (announces that data from its Lymphoseek injection studies in melanoma, breast and oral cavity squamous cell cancers will be presented will be presented at the 68th Annual Cancer Symposium of the Society of Surgical Oncology), MRNS +6.5% (receives FDA Orphan Drug Designation in PCDH19 female epilepsy), BLRX +5.3% (announces successful top-line results from the Phase 1 safety and efficacy study of its lead clinical candidate),RGLS +3.1% (receives Orphan Medicinal Product Designation from the European Commission for RG-012), CLDN +2.7% ( received Emergency Use Authorization from the FDA for Xpert Ebola, a molecular diagnostic test for Ebola Zaire Virus), AHS +2.5% (favorable commentary on Tuesday's Mad Money), WWAV +2.4% (in symp with KRFT), GIS +2% (in symp with KRFT), RIO +1.8% (in connection with TRQ news), MRK +1.6% (announced new $10 bln share repurchase program)
Analyst comments: GRPN +2.8% (upgraded to Buy from Hold at Wunderlich), NTT +1.4% (upgraded to Overweight from Equal Weight at Barclays), URI +0.9% (initiated with a Outperform at Wells Fargo)